B
BPC-157
ProductHeard in 8 episodes across 7 shows since Aug 2026
An experimental peptide studied primarily in preclinical research for tissue repair, inflammation, and angiogenesis; it is not an FDA-approved general medical treatment.
Discussed inHealth & Science67%Markets33%
Episodes
8
across 7 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of BPC-157 per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 13 | 0.07‰ | 2 |
| Sep 1 | 0.06‰ | 2 |
| Sep 8 | 0.04‰ | 1 |
| Sep 12 | 0.07‰ | 1 |
| Sep 17 | 0.06‰ | 1 |
Episodes
8 episodes featuring BPC-157, newest first
- Oct 4, 2026
Three health experts debate routines, hormones, and metabolic healthThe Megyn Kelly ShowOct 4, 2026 - Oct 1, 2026
Sam Sulek argues consistency beats fitness optimizationModern WisdomOct 1, 2026 - Sep 17, 2026
Cellular aging links daily habits to regenerative medicineExtend Podcast with Darshan Shah, MDSep 17, 2026 - Sep 12, 2026
Josh Axe links recovery to personalized cellular healthThe Dylan Gemelli PodcastSep 12, 2026 - Sep 8, 2026
Westall and Letts debate corruption, censorship and political backlashFriday Night Economic ReviewSep 8, 2026 - Sep 1, 2026
MOTS-C Promises Metabolic Gains, But Evidence Remains EarlyThe Dylan Gemelli PodcastSep 1, 2026